Mary C. Graves - Concepedia

Concepedia

Author

Mary C. Graves

La Roche College

Also Known As

M C Graves, M Graves, M. C. Graves, M. Graves, M.C. Graves, Mac Graves, Mary C. Graves, Mary Graves

40

Publications

2.6K

Citations

19

H-Index

75

Concepts

All Affiliations

La Roche College University of North Carolina at Chapel Hill Roche (United Kingdom)Roche (Switzerland)Centre for Human Genetics

MC

About

Mary C. Graves is an author at La Roche College specializing in medicine, natural sciences, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.9K
2	Natural Sciences	10	10	657
3	Engineering	1	1	34
4	Allergy	1	1	33
5	Anatomy	1	1	68

Mary C. Graves

×

22

Publications

2.6K

Citations

19

H-Index

	Year	Citations
Rational Design of a Potent, Long-Lasting Form of Interferon: A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis C Pascal Bailon, Alicia V. Palleroni, Carol Ann Schaffer, Bioconjugate Chemistry Interferon Alpha-2aTranslational MedicineEthylene GlycolHepatologyHepatitis C	2001	609
Cell interactions between histoincompatible T and B lymphocytes. VII. Cooperative responses between lymphocytes are controlled by genes in the I region of the H-2 complex DH Katz, Mary C. Graves, ME Dorf, The Journal of Experimental Medicine HistocompatibilityGeneticsHla ImmunogeneticsImmunologyGenomic Mechanism	1975	276
In vivo and in vitro transcription of the Clostridium pasteurianum ferredoxin gene. Evidence for "extended" promoter elements in gram-positive organisms. Mary C. Graves, Jesse C. Rabinowitz Journal of Biological Chemistry	1986	249
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR Sylvia Knapp, Leland J. Yee, A J Frodsham, Genes and Immunity Interferon-induced GenesDisease SusceptibilityHepatitis CViral HepatitisPathogenesis	2003	220
Effective blocking of HIV‐1 proteinase activity by characteristic inhibitors of aspartic proteinases Anthony D. Richards, R. M. Roberts, Ben M. Dunn, FEBS Letters	1989	166
Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein. Robert L. Shoeman, Bernd Höner, T J Stoller, Proceedings of the National Academy of Sciences ImmunologyProteasomeMolecular BiologyCytoskeletonViral Structural Protein	1990	142
An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity. Mary C. Graves, Jun Jie Lim, Edgar P. Heimer, Proceedings of the National Academy of Sciences Viral ReplicationMolecular BiologyEscherichia ColiViral Structural ProteinProtein Synthesis	1988	136
In Vivo and in Vitro Transcription of the Clostridium pasteurianum Ferredoxin Gene Mary C. Graves, Jesse C. Rabinowitz BacteriologyMolecular BiologyMicrobiologyMolecular MicrobiologyMedicine	1986	115
Positional Isomers of Monopegylated Interferon α-2a: Isolation, Characterization, and Biological Activity Seth P. Monkarsh, Yuemei Ma, Anthony Aglione, Analytical Biochemistry Biological ActivityBioorganic ChemistryBiochemistryMonopegylated Interferon α-2ANatural Sciences	1997	113
Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence A J Frodsham, Lyna Zhang, Uga Dumpis, Proceedings of the National Academy of Sciences ImmunologyHepatitis BGenetic EpidemiologyPathologyIl-10rb Gene	2006	108

Page 1